-
1
-
-
0035379034
-
Chromosome and molecular abnormalities in myelodysplastic syndromes
-
Fenaux P. Chromosome and molecular abnormalities in myelodysplastic syndromes. Int J Hematol 73: 429-437, 2001.
-
(2001)
Int. J. Hematol.
, vol.73
, pp. 429-437
-
-
Fenaux, P.1
-
2
-
-
0027247412
-
Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia
-
Sugimoto K, Hirano N, Toyoshima. H, et al. Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Blood 81: 3022-3326, 1993.
-
(1993)
Blood
, vol.81
, pp. 3022-3326
-
-
Sugimoto, K.1
Hirano, N.2
Toyoshima, H.3
-
3
-
-
0028955808
-
TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities
-
Kaneko H, Misawa S, Horiike S, Nakai H, Kashima K. TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities. Blood 85: 2189-2193, 1995.
-
(1995)
Blood
, vol.85
, pp. 2189-2193
-
-
Kaneko, H.1
Misawa, S.2
Horiike, S.3
Nakai, H.4
Kashima, K.5
-
4
-
-
0030463176
-
TP53 mutations in myelodysplastic syndrome
-
Misawa S, Horiike S. TP53 mutations in myelodysplastic syndrome. Leuk Lymphoma 23: 417-422, 1996.
-
(1996)
Leuk. Lymphoma
, vol.23
, pp. 417-422
-
-
Misawa, S.1
Horiike, S.2
-
5
-
-
0026096185
-
P53 gene mutations in acute myeloid leukemia with 17p monosomy
-
Fenaux P, Jonveaux P, Quiquandon I, et al. P53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood 78: 1652-1657, 1991.
-
(1991)
Blood
, vol.78
, pp. 1652-1657
-
-
Fenaux, P.1
Jonveaux, P.2
Quiquandon, I.3
-
6
-
-
0033952799
-
Lowdose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia
-
Denzlinger C, Bowen D, Benz D, Gelly K, Brugger W, Kanz L. Lowdose melphalan induces favourable responses in elderly patients with high-risk myelodysplastic syndromes or secondary acute myeloid leukaemia. Br J Haematol 108: 93-95, 2000.
-
(2000)
Br. J. Haematol.
, vol.108
, pp. 93-95
-
-
Denzlinger, C.1
Bowen, D.2
Benz, D.3
Gelly, K.4
Brugger, W.5
Kanz, L.6
-
7
-
-
0035725856
-
International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome
-
Kita-Sasai Y, Horiike S, Misawa S, et al. International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome. Br J Haematol 115: 309-312, 2001.
-
(2001)
Br. J. Haematol.
, vol.115
, pp. 309-312
-
-
Kita-Sasai, Y.1
Horiike, S.2
Misawa, S.3
-
8
-
-
0028871987
-
Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia
-
Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukemia. Blood 86: 3542-3552, 1995.
-
(1995)
Blood
, vol.86
, pp. 3542-3552
-
-
Pedersen-Bjergaard, J.1
Pedersen, M.2
Roulston, D.3
Philip, P.4
-
9
-
-
0027241670
-
p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin
-
Campbell C, Quinn AG, Ro YS, Angus B, Rees JL. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 100: 746-748, 1993.
-
(1993)
J. Invest. Dermatol.
, vol.100
, pp. 746-748
-
-
Campbell, C.1
Quinn, A.G.2
Ro, Y.S.3
Angus, B.4
Rees, J.L.5
-
10
-
-
0030909092
-
p53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light
-
Takata M, Rehman I, Rees JL. p53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light. Int J Cancer 71: 370-372, 1997.
-
(1997)
Int. J. Cancer
, vol.71
, pp. 370-372
-
-
Takata, M.1
Rehman, I.2
Rees, J.L.3
-
11
-
-
0034730951
-
p53 gene mutations in Bowen's disease in Koreans: Clustering in exon 5 and multiple mutations
-
Lee HJ, Kim JS, Ha SJ, et al. p53 gene mutations in Bowen's disease in Koreans: clustering in exon 5 and multiple mutations. Cancer Lett 158: 27-33, 2000.
-
(2000)
Cancer Lett.
, vol.158
, pp. 27-33
-
-
Lee, H.J.1
Kim, J.S.2
Ha, S.J.3
-
12
-
-
0035099665
-
Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease
-
Kawakami T, Soma Y, Mizoguchi M, Saito R. Analysis of p53, p21(Waf1/Cip1) and TGF-beta(3) immunohistochemical staining in Bowen's disease. Dermatology 202: 9-15, 2001.
-
(2001)
Dermatology
, vol.202
, pp. 9-15
-
-
Kawakami, T.1
Soma, Y.2
Mizoguchi, M.3
Saito, R.4
-
13
-
-
0025894713
-
p53 mutations in human cancers
-
Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 253: 49-53, 1991.
-
(1991)
Science
, vol.253
, pp. 49-53
-
-
Hollstein, M.1
Sidransky, D.2
Vogelstein, B.3
Harris, C.C.4
-
15
-
-
0030752030
-
Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects
-
Hainaut P, Soussi T, Shomer B, et al. Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res 25: 151-157, 1997.
-
(1997)
Nucleic Acids Res.
, vol.25
, pp. 151-157
-
-
Hainaut, P.1
Soussi, T.2
Shomer, B.3
-
16
-
-
0031804515
-
A database of germline p53 mutations in cancer-prone families
-
Sedlacek Z, Kodet R, Poustka A, Goetz P. A database of germline p53 mutations in cancer-prone families. Nucleic Acids Res 26: 214-215, 1998.
-
(1998)
Nucleic Acids Res.
, vol.26
, pp. 214-215
-
-
Sedlacek, Z.1
Kodet, R.2
Poustka, A.3
Goetz, P.4
-
17
-
-
0034137259
-
Therapy-related leukemia and myelodysplastic syndrome: A large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors
-
Takeyama K, Seto M, Uike N, et al. Therapy-related leukemia and myelodysplastic syndrome: A large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors. Int J Hematol 71: 144-152, 2000.
-
(2000)
Int. J. Hematol.
, vol.71
, pp. 144-152
-
-
Takeyama, K.1
Seto, M.2
Uike, N.3
-
18
-
-
0043098293
-
The myelodysplastic syndromes: Morphology, risk assesment, and clinical management (2002)
-
Bennett JM, Kouides PA, Forman SJ. The myelodysplastic syndromes: Morphology, risk assesment, and clinical management (2002). Int J Hematol 76 (suppl 2): 228-238, 2002.
-
(2002)
Int. J. Hematol.
, vol.76
, Issue.SUPPL. 2
, pp. 228-238
-
-
Bennett, J.M.1
Kouides, P.A.2
Forman, S.J.3
-
19
-
-
0028593972
-
Precursors to skin cancer
-
Sober AJ, Burstein JM. Precursors to skin cancer. Cancer 75 (Suppl 2): 645-650, 1995.
-
(1995)
Cancer
, vol.75
, Issue.SUPPL. 2
, pp. 645-650
-
-
Sober, A.J.1
Burstein, J.M.2
-
21
-
-
0023873472
-
High-dose intravenous methylprednisolone, for idiopathic myelofibrosis
-
Ozsoylu S. High-dose intravenous methylprednisolone, for idiopathic myelofibrosis. Lancet 1: 766, 1988.
-
(1988)
Lancet
, vol.1
, pp. 766
-
-
Ozsoylu, S.1
-
22
-
-
0026816322
-
Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone
-
(in Japanese)
-
Tanosaki R, Uchida H, Masuda Y, et al. Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone. Rinsho Ketsueki (Jpn J Clin Hematol) 33: 256-258, 1992 (in Japanese).
-
(1992)
Rinsho Ketsueki (Jpn. J. Clin. Hematol.)
, vol.33
, pp. 256-258
-
-
Tanosaki, R.1
Uchida, H.2
Masuda, Y.3
-
23
-
-
0028106393
-
Idiopathic myelofibrosis: Anaemia may respond to low-dose dexamethasone
-
Jack FR, Smith SR, Saunders PW. Idiopathic myelofibrosis: anaemia may respond to low-dose dexamethasone. Br J Haematol 87: 877-878, 1994.
-
(1994)
Br. J. Haematol.
, vol.87
, pp. 877-878
-
-
Jack, F.R.1
Smith, S.R.2
Saunders, P.W.3
-
24
-
-
0030095637
-
Primary myelofibrosis with positive coombs' test responding to prednisolone
-
(in Japanese)
-
Yumoto Y, Okuda T, Yoshida Y. Primary myelofibrosis with positive coombs' test responding to prednisolone. Rinsho, Ketsueki (Jpn J Clin Hematol) 37: 255-259, 1996 (in Japanese).
-
(1996)
Rinsho, Ketsueki (Jpn. J. Clin. Hematol.)
, vol.37
, pp. 255-259
-
-
Yumoto, Y.1
Okuda, T.2
Yoshida, Y.3
|